cefuroxime has been researched along with Skin Diseases, Bacterial in 2 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
Skin Diseases, Bacterial: Skin diseases caused by bacteria.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cefuroxime was given in a dosage of 50 to 100 mg/kg/day either intravenously or intramuscularly in equally divided doses every 6 or 8 h." | 2.69 | Efficacy and safety of ampicillin/sulbactam and cefuroxime in the treatment of serious skin and skin structure infections in pediatric patients. UNASYN Pediatric Study Group. ( Azimi, PH; Barson, WJ; Janner, D; Swanson, R, 1999) |
| "Cefuroxime is a drug which balances efficacy with safety." | 1.43 | A Relook of Cefuroxime in Community Infections: An Option Still Beneficial. ( Badhwar, VR; Ganapathy, S; Prabhudesai, PP; Tulara, NK; Varaiya, AY; Vyas, D, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badhwar, VR | 1 |
| Ganapathy, S | 1 |
| Prabhudesai, PP | 1 |
| Tulara, NK | 1 |
| Varaiya, AY | 1 |
| Vyas, D | 1 |
| Azimi, PH | 1 |
| Barson, WJ | 1 |
| Janner, D | 1 |
| Swanson, R | 1 |
1 trial available for cefuroxime and Skin Diseases, Bacterial
| Article | Year |
|---|---|
Efficacy and safety of ampicillin/sulbactam and cefuroxime in the treatment of serious skin and skin structure infections in pediatric patients. UNASYN Pediatric Study Group.
Topics: Ampicillin; Cefuroxime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; | 1999 |
1 other study available for cefuroxime and Skin Diseases, Bacterial
| Article | Year |
|---|---|
A Relook of Cefuroxime in Community Infections: An Option Still Beneficial.
Topics: Anti-Bacterial Agents; Cefuroxime; Community-Acquired Infections; Humans; Respiratory Tract Infectio | 2016 |